| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/08/2004 | WO2004056848A2 Elevation of oil levels in brassica plants |
| 07/08/2004 | WO2004056391A1 A method of immunisation and agents useful for same |
| 07/08/2004 | WO2004056312A2 Immunoglobulin variants and uses thereof |
| 07/08/2004 | WO2004056310A2 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | WO2004056179A2 Genes conferring herbicide resistance |
| 07/08/2004 | WO2004056176A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 07/08/2004 | WO2004056173A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004044150A3 Systems for gene targeting and producing stable genomic transgen e insertions |
| 07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
| 07/08/2004 | WO2004035756A3 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN |
| 07/08/2004 | WO2004035622A3 Antagonists il-15 |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034778A3 Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same |
| 07/08/2004 | WO2004033619A3 Method for assembly of a polynucleotide encoding a target polypeptide |
| 07/08/2004 | WO2004033490A3 Hcmv derived immunomodulatory polypeptide |
| 07/08/2004 | WO2004029235A3 Aldehyde dehydrogenase gene |
| 07/08/2004 | WO2004028464A3 Methods and compositions for modification of splicing of pre-mrna |
| 07/08/2004 | WO2004027032A3 Stearoyl coa desaturase transgenic non-human animals |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004022776A3 Gtp cyclohydrolase ii as a target for fungicides |
| 07/08/2004 | WO2004020580A8 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 07/08/2004 | WO2004018517A3 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 07/08/2004 | WO2004015081A3 Methods for treating circadian rhythm phase disturbances |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004003146A3 Method for improving plant traits by altering the activity of plant g-protein alpha and beta subunits |
| 07/08/2004 | WO2004001027A8 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/08/2004 | WO2004000221A3 Compositions and methods for modulating lymphocyte activity |
| 07/08/2004 | WO2003104413A3 Production of pseudotyped recombinant aav virions |
| 07/08/2004 | WO2003099233A8 Microbial conversion of glucose to para-hydroxystyrene |
| 07/08/2004 | WO2003099213A3 Method for reducing platelet count |
| 07/08/2004 | WO2003092598A3 Treatment for pompe disease |
| 07/08/2004 | WO2003090521A3 Tomato plants that exhibit resistance to botrytis cinerea |
| 07/08/2004 | WO2003089600A3 Surface transfection and expression procedure |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003076899A3 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 07/08/2004 | WO2003076657A8 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes |
| 07/08/2004 | WO2003074565A3 Peptides for use in antitumor immunotherapy |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003069306A3 Protein carrier system for therapeutic oligonucleotides |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003062790A3 Solid phases optimized for chemiluminescent detection |
| 07/08/2004 | WO2003060086A3 Napi type iib polypeptides and methods for making and using same |
| 07/08/2004 | WO2003058021A3 Novel apoptosis-inducing dna sequences |
| 07/08/2004 | WO2003046204A8 Humanized collagen antibodies and related methods |
| 07/08/2004 | WO2003046125A3 Hin-2 nucleic acid molecules, proteins, antibodies, homologues, receptors, and uses thereof |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003027261A3 Methods and compositions for gene targeting by homologous recombination |
| 07/08/2004 | WO2003027233A3 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2002097039A3 Novel human hydroxylases and polynucleotides encoding the same |
| 07/08/2004 | WO2002095058A3 Emission ratiometric indicators of phosphorylation |
| 07/08/2004 | WO2002090926A3 Dose response-based methods for identifying receptors having alterations in signaling |
| 07/08/2004 | WO2002060914A8 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133949 Rice-derived high expression polypeptide chain elongation factor promoter and method of using the same |
| 07/08/2004 | US20040133948 Dwf7 mutants |
| 07/08/2004 | US20040133947 Producing transgenic plant which expresses glutamate dehydrogenase and accumulates high concentrations of glutamic acid, asparagine, aspartic acid, serine, threonine, alanine and histidine in edible parts; tissue engineering |
| 07/08/2004 | US20040133946 Expression vector comprising promoters isolated from corn reproductive system for use as tool in transformation and propagation of disease, insect and herbicide resistant crops; biological pest control and tissue engineering |
| 07/08/2004 | US20040133945 Corn root preferential promoters and uses thereof |
| 07/08/2004 | US20040133944 Seed oil suppression to enhance yield of commercially important macromolecules |
| 07/08/2004 | US20040133943 Characterisation of gene function using double stranded RNA inhibition |
| 07/08/2004 | US20040133942 Comprises insecticidal protein against lepidopteran insect pests; biological pest control and tissue engineering |
| 07/08/2004 | US20040133941 Culture product; contacting cell with stimulus; detection gene expression that induces phenotype |
| 07/08/2004 | US20040133940 Glyphosate tolerant wheat plant 33391 and compositions and methods for detection thereof |
| 07/08/2004 | US20040133939 Using expression vector comprising nucleotide sequences coding glyphosate resistant 5-enol-pyruvylshikimate-3-phosphate synthase (EPSPS) to transform and propagate herbicide resistant crops; chloroplast and tissue engineering |
| 07/08/2004 | US20040133938 Use of lipoic acid in plant culture media |
| 07/08/2004 | US20040133937 Plastid transformation |
| 07/08/2004 | US20040133936 Comprises aphid myrosinase for use as an insecticidal agent when expressed in plants and an antitumor agent when expressed in mammals; biological pest control |
| 07/08/2004 | US20040133935 Preparation method of donor cell for nuclear transfer using electro-stimulation and membrane antigen marker and production method of clone animal |
| 07/08/2004 | US20040133934 Transgenic animals that produce human hemoglobin |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040133932 Genetically engineered mammal for use as bioreactor in expression of heterologous proteins and blood coagulation factors in milk |
| 07/08/2004 | US20040133931 Using electrical pulsation to simultaneously fuse and activate oocytes comprising transfered nucleus; cloning nonhuman mammal |
| 07/08/2004 | US20040133930 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040133313 Method for analyzing readings of nucleic acid assays |
| 07/08/2004 | US20040133114 Zebrafish Assay |
| 07/08/2004 | US20040132984 Oligonuclelotide sequences for use in controlling expression and translation of neutrophil gelatinase associated lipocalin (NGAL) and treatment and prevention of inflammatory bowel disease: RNA interference; gene expression inhibition |
| 07/08/2004 | US20040132983 Comprises nucleotide sequences coding microbial polypeptide for use as diagnostic and therapeutic tools in treatment and prevention of microbial infection |
| 07/08/2004 | US20040132977 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 07/08/2004 | US20040132975 Bacillus chimeric crystal protein with enhanced insecticidal for use in generating and propagating insect resistant plants; biological control agents; pest control |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132972 Tri-hybrid melanoma antigen |
| 07/08/2004 | US20040132957 Precursors of silk-like materials, silk-like materials and processes for producing both |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132683 Expression of exogenous polynucleotide sequences in a vertebrate |
| 07/08/2004 | US20040132682 Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides |
| 07/08/2004 | US20040132681 Antisense modulation of beta-site APP-cleaving enzyme 2 expression |
| 07/08/2004 | US20040132680 Beta secretase transgenic organisms and methods of use thereof |
| 07/08/2004 | US20040132679 Induction of pancreatic islet formation |
| 07/08/2004 | US20040132678 Recombinant double-stranded RNA phage, and use of the same |
| 07/08/2004 | US20040132676 Polynucleotide formulation for enhanced intracellular transfer |
| 07/08/2004 | US20040132675 Drug deliverying an angiogenesis inhibitor, reduce the side effect of chemotherapy and radiation therapy, increase red blood cells; truncated, soluble Flk1/KDR receptor, recombinant protein; inhibitor of vascular endothelial growth factor |
| 07/08/2004 | US20040132674 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132654 Increased content of high molecular weight multimers; hemophilia and blood disorder treatment |
| 07/08/2004 | US20040132648 Remedies and/or preventives for conformational diseases |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |